Weekly Snapshot Aug 03- 07, 2020

 1 Bausch Health to Spin off its Eye Health Business

Published: Aug 06, 2020 | Tags: Bausch Health, Spin off, Eye Health Business, Bausch + Lomb

2.  AstraZeneca Collaborates with Daiichi Sankyo to Evaluate the Combination of Patritumab Deruxtecan (U3-1402) + Tagrisso for EGFR-Mutated Non-Small Cell Lung Cancer

Published: Aug 07, 2020 | Tags: AstraZeneca, Collaborates, Daiichi Sankyo, Evaluate, Combination, Patritumab Deruxtecan, U3-1402, Tagrisso, EGFR-Mutated, Non-Small Cell Lung Cancer

 3. Roche’s Tecentriq (atezolizumab) + Paclitaxel Fail to Meet the Primary Endpoint in P-III IMpassion131 Study for Patients with Metastatic Triple-Negative Breast Cancer

Published: Aug 07, 2020 | Tags: Roche, Tecentriq, atezolizumab, + Paclitaxel, Fail,  Meet, Primary Endpoint, P-III, IMpassion131, Study,  Patients, Metastatic, Triple-Negative Breast Cancer

4. Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson’s Disease Worth ~$2.125B

Published: Aug 06, 2020 | Tags: Biogen, Signs, Agreement, Denali, LRRK2 Program, Parkinson’s Disease, Worth, ~$2.125B

5. Cadila Pharma Launches NuPTH Biosimilar to Forteo for the Treatment of Osteoporosis in India

Published: Aug 07, 2020 | Tags: Cadila Pharma, Launches, NuPTH, Biosimilar, Forteo, Treatment, Osteoporosis, India

6. Vela Diagnostics’ ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA’s Emergency Use Authorization

Published: Aug 07, 2020 | Tags: Sangamo, Signs, Worldwide, License Agreement, Novartis, Develop, Genomic Therapies, Three, Neurodevelopmental Targets

7.  Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements

Published: Aug 05, 2020 | Tags: Moderna, Prices, COVID-19 Vaccine, $32-$37, Dose, Smaller Volume Agreements

8.  UCB’s Cimzia (certolizumab pegol) Receives the EMA’s Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthritis Spectrum

Published: Aug 06, 2020 | Tags: UCB, Cimzia, certolizumab pegol, Receives, EMA, Approval, Reduced, Maintenance Dose,  Patients, Axial Spondyloarthritis Spectrum

9. Lundbeck Halts P-II Study of Lu AF11167 in Patients with Negative Symptoms of Schizophrenia

Published: Aug 05, 2020 | Tags: Lundbeck, Halts, P-II, Study, Lu AF11167, Patients, Negative, Symptoms, Schizophrenia

10. UCB Canada’s Brivlera (brivaracetam) Receives Health Canada Approval to Treat Partial-Onset Seizures in Pediatric Epilepsy Patients

Published: Aug 06, 2020 | Tags: UCB Canada, Brivlera, brivaracetam, Receives, Health Canada, Approval, Treat, Partial-Onset Seizures, Pediatric, Epilepsy Patients

11. Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS Trials for Relapsing Multiple Sclerosis

Published: Aug 05, 2020 | Tags: Novartis, Reports, Results, Ofatumumab, OMB157, P-III, ASCLEPIOS, Trials, Relapsing Multiple Sclerosis

13.  AstraZeneca Collaborates with Eko to Advance the Digital Health Tools for the Diagnosis of CV Diseases

Published: Aug 06, 2020 | Tags: AstraZeneca, Collaborates, Eko, Advance, Digital Health, Tools, Diagnosis, CV, Diseases

14. Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B

Published: Aug 06, 2020 | Tags: Johnson & Johnson, Signs, Agreement, US, Government, Supply, 100M, Doses, COVID-19, Vaccine, Worth, ~$1B

15. Teva and Alvotech Collaborate to Commercialize Five Biosimilar Candidates in the US

Published: Aug 05, 2020 | Tags: Teva, Alvotech, Collaborate, Commercialize, Five Biosimilar, Candidates, US

16.  Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India

Published: Aug 04, 2020 | Tags: Lupin, SunPharma, Launch, Generic Favipiravir, Treat, Mild, Moderate, COVID-19

17.   BioNTech and Fosun Pharma Initiate Clinical Trial of BNT162b1 Against COVID-19 in China

Published: Aug 05, 2020 | Tags:  BioNTech, Fosun Pharma, Initiate, Clinical Trial, BNT162b1, Against, COVID-19, China

18.  AbbVie Terminates Tau and ASN Agreement with Voyager Signed in 2018 and 2019

Published: Aug 05, 2020 | Tags: AbbVie, Terminates, Tau, ASN, Agreement, Voyager, Signed, 2018, 2019

19.  Roche’s cobas Epstein-Barr Virus Test Receives the US FDA’s Authorization for Transplant Patients

Published: Aug 05, 2020 | Tags: Eli Lilly, P-tau217, Blood Test, Demonstrate, High Accuracy, Diagnosis, Alzheimer’s Disease

20.   LEO Pharma Receives the US FDA’s Fast Track Designation for Delgocitinib Cream to Treat Moderate-to-Severe Chronic Hand Eczema

Published: Aug 04, 2020 | Tags: LEO Pharma, Receives, US, FDA, Fast Track Designation, Delgocitinib Cream, Treat, Moderate-to-Severe, Chronic Hand Eczema

21.  AstraZeneca Signs a License Agreement with Redx Pharma for RXC006 to Treat Idiopathic Pulmonary Fibrosis

Published: Aug 03, 2020 | Tags: AstraZeneca, Signs, License Agreement, Redx Pharma, RXC006, Treat, Idiopathic Pulmonary Fibrosis, Globally

22. Janssen’s Darzalex (daratumumab, SC) Receives Health Canada Approval for the Treatment of Patients with Multiple Myeloma

Published: Aug 04, 2020 | Tags: Janssen, Darzalex, daratumumab, SC, Receives, Health Canada, Approval, Treatment, Patients, Multiple Myeloma

23.  Siemens Healthineers to Acquire Varian for $16.4B

Published: Aug 03, 2020 | Tags: Siemens Healthineers, Acquire, Varian, $16.4B

24. Merck and Hanmi Collaborate to Develop Efinopegdutide for NASH

Published: Aug 04, 2020 | Tags: Merck, Hanmi, Collaborate, Develop, Efinopegdutide, NASH

25. Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19

Published: Aug 03, 2020 | Tags: Eli Lilly, Collaboration, NIAID, Initiate, P-III, Study, LY-CoV555, Prevent, COVID-19

26.  Novartis Reports Results of Kymriah (tisagenlecleucel) in P-II ELARA Study for Follicular Lymphoma

Published: Aug 02, 2020 | Tags:  Novartis, Reports, Results, Kymriah, tisagenlecleucel, P-II, ELARA Study, Follicular Lymphoma

27. Sanofi and GSK Receive $2.1B from the US Government to Supply 100M Doses of COVID-19 Vaccine

Published: Aug 01, 2020 | Tags: Sanofi, GSK, Receive, $2.1B, US, Government, Supply, 100M, Doses, COVID-19, Vaccine

28.   Roche’s Rozlytrek Receives EC’s Conditional Marketing Authorization for NTRK Fusion-Positive Solid Tumors and ROS1-Positive Advanced NSCLC

Published: Aug 03, 2020 | Tags: Roche, Rozlytrek, Receives, EC, Conditional Marketing Authorization, NTRK Fusion-Positive, Solid Tumors, ROS1-Positive, Advanced, NSCLC

29.   Regeneron Collaborates with BioNTech to Advance the Combination of FixVac and Libtayo (cemiplimab) in Melanoma

Published: Aug 02, 2020 | Tags: Regeneron, Collaborates, BioNTech, Advance, Combination, FixVac, Libtayo, cemiplimab, Melanoma

30. Immunic Reports Results of IMU-838 in P-II EMPhASIS Study in Patients with Relapsing-Remitting Multiple Sclerosis

Published: Aug 01, 2020 | Tags: Immunic, Reports, Results, IMU-838, P-II, EMPhASIS Study, Patients, Relapsing, Remitting, Multiple Sclerosis

31. MorphoSys’ Monjuvi (tafasitamab-cxix) + Lenalidomide Receives the US FDA’s Approval as 2L Treatment for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Published: Aug 02, 2020 | Tags: MorphoSys, Monjuvi, tafasitamab-cxix, Lenalidomide, Receives, US, FDA, Approval, 2L, Treatment, Patients, Relapsed, Refractory, Diffuse Large B-cell Lymphoma

32.  RedHill Replaces its Co-Commercialization Agreement with Daiichi Sankyo for Movantik (naloxegol)

Published: Aug 02, 2020 | Tags: RedHill, Replaces, Co-Commercialization, Agreement, Daiichi Sankyo, Movantik, naloxegol